CClinicalTrials.gg
CompletedNCT00967265Updated Sep 5, 2018

Introduction Seminar About Patient Participation and Treatment Options for Psychiatric Patients on Waiting List

An interventional study of Introduction seminar and Usual care in Mental Disorders, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-09-05.

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Patient participation is a central concept in Norwegian health policy. It is mandatory in hospitals and emphasised as one of the most prioritised areas by the Government. Studies from Norway have repeatedly found that patients who seek help in community mental health centres ("DPS") are dissatisfied with the information they receive and about their possibility for real influence in their treatment.

One way to improve individual patient participation might be to give patients information before they start their treatment. This can be done as group based patient education to reduce the resources needed. Furthermore, as there are waiting lists for treatment, such introduction seminars could be held while patients are waiting to use this time in a meaningful way.

The present study therefore aims at testing the effect of an introduction seminar for patients on waiting list in a community mental health centre.

02

Conditions studied

  • Mental Disorders

Keywords

  • Introduction seminar
  • Psychoeducation
  • Waiting list
  • Patient participation
  • Mental disorders
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's enrollment of 92 is close to the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients older than 18 years referred for out patient treatment who get a guarantee of starting treatment between 2 and 6 months will be included.

Exclusion criteria

Exclusion Criteria:

  • patients with a guarantee of starting treatment in less than two months and
  • patients who do not understand the consequences of taking part in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
92 participants (actual)

Study arms

  • Experimental
    Introduction seminar

    Psychoeducation for patients on waiting list

    Behavioral: Introduction seminar

  • Active comparator
    Usual care

    Usual care

    Other: Usual care

Interventions

  • BehavioralIntroduction seminar

    The seminar will be held over two half days, each lasting 2.5 hours. Up to 30 patients can participate in each seminar. The details of the content of the program will be developed based on study one. The preliminarily plans are to give general information about the community mental health centre, the available treatment options and patients rights by presentations from health personnel and user representatives. At the end of each day, the patients will be divided into small groups mentored by health personnel were they can discuss the presentations and ask questions. In the breaks, literature and other type of information for patients will be on display. All participants will get a folder with details of the program and leaflets from patient organisations and governmental agencies.

    Also known as: psychoeducation

  • OtherUsual care

    Usual care

06

What researchers measure

Primary outcomes

  1. Behavior and symptoms

    Behavior and Symptom Identification Scale (BASIS-32)

    Time frame: 12 months

  2. knowledge on treatment preference

    Time frame: 1 month

  3. patient activation (coping)

    measured with Patient Activation Measure (PAM)

    Time frame: 4 months

Secondary outcomes

  1. Client satisfaction

    Satisfaction measured with Client Satisfaction Questionnaire (CSQ-8)

    Time frame: Baseline, 4 and 12 months

  2. Perceived participation

    Perceived participation measured with Perception of care (PoC)

    Time frame: Baseline, 4 and 12 months

  3. Psychiatric Out-Patient Experiences

    Psychiatric Out-Patient Experiences Questionnaire (POPEQ)

    Time frame: Baseline, 4 and 12 months

  4. Quality of Life

    WHO-5

    Time frame: Baseline, 4 and 12 months

  5. motivation for treatment

    motivation for treatment (questions)

    Time frame: Baseline, 1 and 4 months

  6. costs

    data on health care use, sick leave, medication and other direct and indirect costs will be collected

    Time frame: Baseline, 1, 4 and 12 months

  7. Knowledge

    measured using a self developed questionnaire

    Time frame: Baseline, 1, 4 and 12 months

07

Study locations

1 site
  • Tiller DPS
    Trondheim, 7055, Norway
08

References and documents

Publications

  • Koksvik JM, Linaker OM, Grawe RW, Bjorngaard JH, Lara-Cabrera ML. The effects of a pretreatment educational group programme on mental health treatment outcomes: a randomized controlled trial. BMC Health Serv Res. 2018 Aug 29;18(1):665. doi: 10.1186/s12913-018-3466-2. PubMed 30157839 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00967265
Lead sponsor
Norwegian University of Science and Technology
Collaborators
Helse Nord-Trøndelag HF
Responsible party
Sponsor
First posted
Aug 27, 2009
Start date
Jun 2009
Primary completion
Jun 2011
Completion
Jul 2012
Last update
Sep 5, 2018

Study contacts

Aslak Steinsbekk, PhD
principal investigator · Norwegian University of Science and Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion